BPC-157
500mcg · 60 capsules
- Ships same or next day Orders before 3PM EST, FedEx 2-Day Air
- Verify this lot View the lab report
- Real U.S. support Live chat and email, 7 days a week
For research use only. Not for human or veterinary consumption.
Certified-Pep only sells U.S.-made peptides and products.
Key Features:
Made in the USA
Batch tested at a verifiable U.S. laboratory for identity, content and purity
Screened for endotoxins, heavy metals and sterility
Rigorous quality testing on every batch
Capsule form for precise research. Capsules are not intended for time release purposes, transport only
For laboratory and research use only
- CAS: 137525-51-0
- FORM: Encapsulated Peptide: Acetate (Salt form)
- CONTENT PER CAPSULE: 500 MCG
- PURITY: 99%+
| BPC-157 500 mcg 60 CAPSULES | |
|---|---|
| SKU | ORAL_CP_BPC_157_500MCG_60_CAP |
| CATEGORY | Peptide Capsules |
| CAS | 137525-51-0 |
| PACKAGE SIZE | 60 capsules per unit |
| FORM | Encapsulated Peptide: Acetate (Salt form) |
| MOLECULAR WEIGHT | 1419.56 g/mol |
| SEQUENCE | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| MOLECULAR FORMULA | C62H98N16O22 |
| ITEM ID | 52083 |
Yıldırım et al. (2026) evaluated BPC-157 in a rat model of lower-limb ischemia-reperfusion (I/R) injury. In the BPC-157-treated I/R group, the investigators reported reduced malondialdehyde (MDA) and total oxidant status (TOS) levels compared with untreated I/R controls, alongside partial restoration of superoxide dismutase (SOD) and total antioxidant status (TAS). [1] Gene expression analysis showed downregulation of p53, Bax, and Caspase-3 mRNA, with upregulation of Bcl-2 mRNA. Immunohistochemistry indicated reduced IL-6 and Caspase-3 immunoreactivity and partial restoration of VEGF expression. Histological scoring showed improved skeletal muscle architecture and reduced collagen deposition in the treated group relative to untreated I/R controls. The authors noted that further studies are needed [2].
More capsules.
Single-vial pricing
Add to cart
Sale
